113 related articles for article (PubMed ID: 8103806)
1. Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma.
Uchida T; Wada C; Shitara T; Egawa S; Mashimo S; Koshiba K
J Urol; 1993 Oct; 150(4):1298-301. PubMed ID: 8103806
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
[TBL] [Abstract][Full Text] [Related]
4. The 72nd codon change of p53 in primary renal cell carcinoma was confirmed as a polymorphism among Japanese.
Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
Eur Urol; 1997; 31(1):81-5. PubMed ID: 9032540
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor.
Lee JH; Kang YS; Park SY; Kim BG; Lee ED; Lee KH; Park KB; Kavanagh JJ; Wharton JT
Cancer Genet Cytogenet; 1995 Nov; 85(1):43-50. PubMed ID: 8536236
[TBL] [Abstract][Full Text] [Related]
10. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
11. Infrequent alteration of the DPC4 tumor suppressor gene in renal cell carcinoma.
Popović Hadzija M; Hrasćan R; Bosnar MH; Zeljko Z; Hadzija M; Cadez J; Pavelić K; Kapitanović S
Urol Res; 2004 Jun; 32(3):229-35. PubMed ID: 15107966
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M
Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563
[TBL] [Abstract][Full Text] [Related]
13. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
14. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
[TBL] [Abstract][Full Text] [Related]
15. Allelotype of renal cell carcinoma.
Morita R; Ishikawa J; Tsutsumi M; Hikiji K; Tsukada Y; Kamidono S; Maeda S; Nakamura Y
Cancer Res; 1991 Feb; 51(3):820-3. PubMed ID: 1670999
[TBL] [Abstract][Full Text] [Related]
16. Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.
Suzuki Y; Tamura G; Maesawa C; Fujioka T; Kubo T; Satodate R
Virchows Arch; 1994; 424(5):453-7. PubMed ID: 8032525
[TBL] [Abstract][Full Text] [Related]
17. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Suzuki Y; Tamura G; Satodate R; Fujioka T
Jpn J Cancer Res; 1992 Mar; 83(3):233-5. PubMed ID: 1582882
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 gene in carcinomas of the urinary system.
Suzuki Y; Tamura G
Acta Pathol Jpn; 1993 Dec; 43(12):745-50. PubMed ID: 8109252
[TBL] [Abstract][Full Text] [Related]
19. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.
Cogen PH; Daneshvar L; Metzger AK; Duyk G; Edwards MS; Sheffield VC
Am J Hum Genet; 1992 Mar; 50(3):584-9. PubMed ID: 1347196
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations and prognosis in bladder tumors.
Uchida T; Wada C; Ishida H; Wang C; Egawa S; Yokoyama E; Kameya T; Koshiba K
J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
